MYO · Myomo, Inc.

0001193125-26-159060

Summary

On April 14, 2026, Myomo, Inc. appointed William J. Febbo as a Class II director to serve until the 2028 annual meeting, granting him 45,000 RSUs and a $145,000 annual compensation package.

Key takeaways

William J. Febbo appointed to Board as Class II director effective April 14, 2026, expanding the Board to six directors.
Febbo brings over 30 years of experience in healthcare and technology, currently serving as CEO of Performance Health Systems.
Initial grant of 45,000 RSUs vests fully on the first anniversary of the appointment date.
Annual compensation includes a $60,000 cash retainer and $85,000 in RSUs vesting over four quarters.
Febbo previously served as CEO of OptimizeRx (NASDAQ: OPRX) from 2015 to 2024, growing revenue from $5M to $92M.

Full analysis

Myomo, Inc. appointed William J. Febbo to its Board of Directors effective April 14, 2026. Mr. Febbo will serve as a Class II director until the 2028 annual meeting of shareholders. With this appointment, the Board now comprises six directors. Mr. Febbo has not been appointed to serve on any Board committees at this time. He has entered into an indemnification agreement consistent with the Company's existing non-employee directors.